The Cancer of the Pancreas Screening-5 Study
The Cancer of the Pancreas Screening-5 Study (CAPS5 Study)
Sponsor: AACR Johns Hopkins University
Enrolling: Male and Female Patients
IRB Number: AAAM7800
U.S. Govt. ID: NCT02000089
Contact: Fay Kastrinos, MD: 212-305-9337 / fk18@cumc.columbia.edu
Additional Study Information: Pancreatic cancer is a deadly disease and the best hope for improving the chances of survival is to find it early. Some patients, called high-risk, have an inherited predisposition to pancreatic cancer. Certain medical centers have started programs where high-risk patients undergo testing, such as receiving imaging scans, to look for early signs of pancreatic cancer. However, these tests are not able to pick up all early signs of cancer. Therefore, in this study, we are collecting samples of the patient's blood, pancreatic juice, and samples of any biopsy or surgery to search for other early signs of cancer, which we call markers. Patients will undergo standard medical care, such as receiving medical evaluation by a specialist, endoscopy, and imaging scans, as well as be subject to the collection of extra information via questionnaires and collection of extra blood and pancreatic juice specimens. By collecting this information and samples, we hope to identify markers for pancreatic cancer, which will help patients at risk of developing this disease.
Investigator
Fay Kastrinos, MD
Do You Qualify?
Do you have a family history of pancreatic cancer (listed in description)? (Mark yes if you will answer yes to Q2) Yes No
Do you have genetic syndromes that could raise your risk (listed in description)? (Mark yes if you answered yes to Q1.) Yes No
Submit
Cancel
You may be eligible for this study

Place Holder




For more information, please contact:
Fay Kastrinos, MD
fk18@cumc.columbia.edu
212-305-9337